Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.4.A. b, e
Nishitani E et al. (2015)
|
Xla Wt + pou3f2
NF10.5 (in situ hybridization)
|
|
|
|
fig.4.A. c, f
Nishitani E et al. (2015)
|
Xla Wt + pou5f3.2 MO
NF10.5 (in situ hybridization)
|
|
|
|
fig.1.m
Wang C et al. (2015)
|
Xla Wt + su5402
NF16 (in situ hybridization)
|
|
|
|
fig.1.n
Wang C et al. (2015)
|
Xla Wt + su5402
NF16 (in situ hybridization)
|
|
|
|
fig.3.b
Sun G et al. (2015)
|
Xla Wt + ctdspl MO
NF10.5 (morphology)
|
|
|
|
Fig.6.A
Iwasaki Y and Thomsen GH (2014)
|
Xla Wt + bmp4 + animal cap explant
NF10.5 (RT-PCR)
|
|
|
|
Fig.6.B,C
Iwasaki Y and Thomsen GH (2014)
|
Xla Wt + fgf4 + animal cap explant
NF10.5 (RT-PCR)
|
|
|
|
Fig.5
Iwasaki Y and Thomsen GH (2014)
|
Xla Wt + pqbp1 MO
NF10.5 (RT-PCR)
|
|
|
|
Fig.3.A
Iwasaki Y and Thomsen GH (2014)
|
Xla Wt + pqbp1 MO
NF12.5 (in situ hybridization)
|
|
|
|
Fig.S4
Iwasaki Y and Thomsen GH (2014)
|
Xla Wt + pqbp1 MO
NF13 (in situ hybridization)
|
|
|